Navigation Links
ViroPharma To Acquire Lev Pharmaceuticals
Date:7/15/2008

Additionally, ViroPharma agreed to make a $20 million investment in Lev, at signing, by purchasing 9,661,836 shares of Lev common stock at a 10 percent premium to the five day average closing price of Lev's shares for the period ending Friday, July 11, 2008, sold pursuant to Lev's effective registration statement on Form S-3.

J.P. Morgan Securities Inc. advised ViroPharma and DLA Piper acted as legal counsel. In addition, Piper Jaffray & Co. provided a fairness opinion to ViroPharma's board of directors. J.P. Morgan Securities Inc., as successor to Bear, Stearns & Co. Inc., advised Lev and provided a fairness opinion to Lev's board of directors. Willkie Farr & Gallagher LLP and Becker & Poliakoff, LLP acted as legal counsel to Lev.

Conference Call and Webcast Information

ViroPharma will host a live teleconference and webcast (featuring slide presentation) with senior management to discuss the strategic acquisition of Lev Pharmaceuticals on Tuesday, July 15, 2008 at 10:30 a.m. ET. Members of Lev Pharmaceuticals senior management will be available during the question and answer period. To participate in the conference call, please dial 888-299-4099 (domestic) and 302-709-8337 (international). After placing the call, please tell the operator you wish to join the ViroPharma investor conference call.

Alternatively, the live webcast of the conference call and slide presentation can be accessed via ViroPharma's website at http://www.viropharma.com. Windows Media or Real Player will be needed to access the webcast. An audio archive will be available at the same address until August 1, 2008.

Cinryze(TM) Regulatory Status

On May 2, 2008, the Blood Products Advisory Committee (BPAC) to the U.S. Food and Drug Administration (FDA) voted unanimously that there is sufficient evidence of the safety and efficacy for the approval of Cinryze for the prophylactic treatment of HAE. Th
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. ViroPharma to Present at Two Upcoming Healthcare Conferences
2. ViroPharma Provides 2008 Outlook
3. ViroPharma to Present at the BIO CEO & Investor Conference
4. ViroPharma to Release 2007 Fourth Quarter and Full Year Financial Results on February 27, 2008
5. ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference
6. ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
7. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
8. ViroPharma to Present at Two Upcoming Healthcare Conferences
9. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
10. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
11. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... NJ (PRWEB) October 02, 2014 At a ... Bel-Art Products has introduced a new kind of ... to market is the Scienceware® Squeeze Rite™ Wash Bottle ... dip tube position within the bottle reduces the waste of ... dispensing of those liquids. , “Easier to squeeze when compared ...
(Date:10/2/2014)... , Oct. 2, 2014  CSSi ( www.CSSiEnroll.com ... the clinical research industry, is pleased to announce ... the month of October.  President Chris Trizna ... annual Outsourcing in Clinical Trials New England conference ... participating in the annual Site Solutions Summit sponsored ...
(Date:10/2/2014)... and BRIDGEWATER, N.J. ... XON) , a leader in synthetic biology, and ... generic drug manufacturer by volume in the U.S., ... Channel Collaboration (ECC) for a target active pharmaceutical ... the goal of the collaboration is to develop ...
(Date:10/1/2014)... What: , Cambridge Semantics, the ... Semantic Web technology, today announced its participation in the ... , Smart Data solutions provide semantic linkage and meaning ... understand, analyze and manage diverse data. Ben Szekely, vice ... on building a “life sciences data lake” and an ...
Breaking Biology Technology:New Wash Bottle Reduces Waste of Reagents, Solutions, and Other Liquids 2Patient Recruitment Expert CSSi to be Featured at Upcoming Industry Events 2Patient Recruitment Expert CSSi to be Featured at Upcoming Industry Events 3Intrexon and Amneal Expand Relationship with Second Product Collaboration 2Intrexon and Amneal Expand Relationship with Second Product Collaboration 3Cambridge Semantics to Present ‘A Useful Approach to Big Data’ at 2014 Big Data Leaders Forum 2
... , , , , , Multiporator / Electroporator 2510 , , , ... Transformation Protocol , Protocol No. 4308 915.502 12/2001 , ... , , , , , ... , Cell type , Bacteria, ...
... , , Multiporator , , , , , , ... Protocol No. 4308 915.044 11/2001 , , ... , , Cell line , ... negative, , MHC class II positive, , ...
... , Multiporator / Electroporator 2510 , , , , , , ... Protocol , Protocol No. 4308 915.541 03/2002 , , ... , , Microorganism , ... Cell type , Bacteria, gram positive, , ...
Cached Biology Technology:Agrobacterium tumefaciens 2721.221 2Streptococcus salivarius 2
(Date:10/1/2014)... researchers hope to take a healthy salad up a ... of breast cancer in leafy greens. , "In the ... either by eating the salad or making a pill ... of biomedical engineering at Case Western Reserve School of ... G. Komen breast cancer organization is funding the research ...
(Date:10/1/2014)... 2014 Novel detection technology ... field  The life science field has ... the years. Some are shooting stars and others ... novel detection technology that has raised much enthusiasm ... technology is becoming commercially available. With their unique ...
(Date:9/30/2014)... the Mediterranean each year, but its deep-blue waters ... Almost 1,000 alien species, including fish, crustaceans, and ... human activities. In the open-access journal Frontiers ... researchers analyzed data from a new information system ... the introduction of alien species has changed the ...
Breaking Biology News(10 mins):Scientists wield plant viruses against deadly human disease 2Scientists wield plant viruses against deadly human disease 3First-of-a-kind Solution for Utilizing Photon Upconversion 2Biodiversity in the Mediterranean is threatened by alien species 2
... If you think stress is killing you, you may be ... have harmed your health even before you were born. In ... The FASEB Journal , Harvard researchers find ... in life, are already common at birth. Possibly, these aberrations ...
... researchers administered a new method for treating chronic wounds ... like a band-aid. The applicator delivers low-frequency, low-intensity ultrasound ... healing in five patients with venous ulcers. Venous ulcers ... blood to pool in the leg instead of returning ...
... Cambridge scientists have identified an ,on/off, switch in a type ... called ,malignant germ cell tumours,. The research was published today, ... Malignant germ cell tumours arise in sperm- or egg-forming cells ... ovaries. The cancerous tumours are seen in patients of all ...
Cached Biology News:Fetal stress disrupts the way genes are transmitted 2Ultrasound patch heals venous ulcers in human trial 2Ultrasound patch heals venous ulcers in human trial 3Ultrasound patch heals venous ulcers in human trial 4Scientists discover a molecular 'switch' in cancers of the testis and ovary 2
Goat polyclonal to JIK ( Abpromise for all tested applications). Antigen: Synthetic peptide: HKKDHVFIRDEAGHGD, corresponding to amino acids 396-411 of Human JIK. Entrez Gene ID: 51347 Swi...
Mouse monoclonal [SPM325] to Xanthine Oxidase, prediluted ( Abpromise for all tested applications). Antigen: C terminal 358 amino acid fragment of human xanthine oxidase. Entrez Gene ID: 749...
Rab1A...
Drugs and NO-drug Rat Anti-conjugated Acetyl Salicylic Acid Polyclonal Antibody...
Biology Products: